ReportsandReports - Drug Discovery Collaborations Between Academia and the Pharmaceutical Industry: Cultural Factors, Intellectual Property Considerations, Case Studies, and Future Trends
The pharmaceutical and biopharmaceutical industries are engaged in a business environment which is witnessing a dramatic escalation of R&D costs, key patent expiries, and sustained high attrition rates for new molecules in development.
View full press release